ASIT BIOTECH S.A.
Share · BE0974289218 · A2AJLU (XBRU)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ASIT BIOTECH S.A.
No Price
Company Profile for ASIT BIOTECH S.A. Share
DMS Imaging SA, a biopharmaceutical company, focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies in Belgium and internationally. Its lead product is gp-ASIT+, which is in the Phase III trial for the treatment of grass pollen rhinitis. The company is also developing hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy. ASIT Biotech S.A. was incorporated in 1997 and is based in Liege, Belgium.
Company Data
Name ASIT BIOTECH S.A.
Company DMS Imaging S.A.
Website
https://www.dms-imaging.com
Primary Exchange 
EURONEXT - EURONEXT BRUSSELS
EURONEXT - EURONEXT BRUSSELS
WKN A2AJLU
ISIN BE0974289218
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Thierry Legon
Country Belgium
Currency EUR
Employees 0,0 T
Address 7 Rue des Chasseurs Ardennais, Liege (Angleur), 4031 Liege
IPO Date 2016-05-11
Ticker Symbols
| Name | Symbol |
|---|---|
| EURONEXT - EURONEXT BRUSSELS | ASIT.BR |
| Frankfurt | AS0.F |
| London | 0RGO.L |
More Shares
Investors who hold ASIT BIOTECH S.A. also have the following shares in their portfolio:
